Infinity Pharmaceuticals Financial Statements Trends

INFI -- USA Stock  

USD 1.91  0.07  3.54%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Interest Expense of 1.6 M or Operating Expenses of 277.9 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 5.4358 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.

Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets288.8 M288.8 M230.6 M
Increasing
Slightly volatile
Cash and Equivalents47.8 M189.9 M105.3 M
Increasing
Slightly volatile
Investments67.1 M57.1 M85.3 M
Decreasing
Slightly volatile
Investments Current67.1 M57.1 M84.9 M
Decreasing
Slightly volatile
Investments Non Current610.6 K519 K612.7 K
Decreasing
Slightly volatile
Deferred Revenue154 M130.9 M90.4 M
Increasing
Slightly volatile
Inventory2.8 M2.4 M2.6 M
Decreasing
Slightly volatile
Trade and Non Trade Receivables2.1 M1.8 M3 M
Decreasing
Slightly volatile
Trade and Non Trade Payables11.3 M9.6 M8.5 M
Increasing
Slightly volatile
Goodwill and Intangible Assets2.2 M1.9 M2 M
Decreasing
Stable
Total Liabilities223.8 M190.3 M110.7 M
Increasing
Slightly volatile
Shareholders Equity115.9 M98.6 M124.1 M
Increasing
Stable
Accumulated Retained Earnings Deficit(700.7 M)(595.6 M)(388.2 M)
Decreasing
Slightly volatile
Accumulated Other Comprehensive Income52.9 K45 K199.4 K
Decreasing
Slightly volatile
Current Assets254.7 M254.7 M208.3 M
Increasing
Slightly volatile
Assets Non Current40.1 M34.1 M22.8 M
Increasing
Slightly volatile
Current Liabilities70.1 M70.1 M39.6 M
Increasing
Slightly volatile
Liabilities Non Current141.4 M120.2 M70.1 M
Increasing
Slightly volatile
Total Debt23.5 M20 M21.5 M
Increasing
Stable
Debt Current489.4 K416 K466.9 K
Decreasing
Stable
Debt Non Current23 M19.6 M21.1 M
Increasing
Stable
Shareholders Equity USD115.9 M98.6 M124.1 M
Increasing
Stable
Cash and Equivalents USD223.4 M189.9 M119.9 M
Increasing
Slightly volatile
Total Debt USD23.5 M20 M21.5 M
Increasing
Stable

Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues6 M109.1 M87.8 M
Increasing
Stable
Cost of Revenue32.5 M27.6 M28 M
Increasing
Slightly volatile
Research and Development Expense234.2 M199.1 M127.3 M
Increasing
Slightly volatile
Operating Expenses277.9 M236.2 M151.4 M
Increasing
Slightly volatile
Interest Expense1.6 M1.4 M2.7 M
Increasing
Stable
Income Tax Expense394.1 K335 K155 K
Increasing
Stable
Consolidated Income(151 M)(128.4 M)(69.1 M)
Decreasing
Slightly volatile
Net Income(40.8 M)(128.4 M)(60 M)
Decreasing
Slightly volatile
Net Income Common Stock(151 M)(128.4 M)(69.1 M)
Decreasing
Slightly volatile
Weighted Average Shares56.1 M49.1 M36.4 M
Increasing
Slightly volatile
Weighted Average Shares Diluted57.7 M49.1 M36.6 M
Increasing
Slightly volatile
Earning Before Interest and Taxes EBIT(149 M)(126.7 M)(67.2 M)
Decreasing
Slightly volatile
Revenues USD128.3 M109.1 M98 M
Increasing
Slightly volatile
Net Income Common Stock USD(151 M)(128.4 M)(69.1 M)
Decreasing
Slightly volatile
Earning Before Interest and Taxes USD(149 M)(126.7 M)(67.2 M)
Decreasing
Slightly volatile
Gross Profit(14.8 M)109.1 M83.8 M
Increasing
Stable
Operating Income(149.5 M)(127.1 M)(69.4 M)
Decreasing
Slightly volatile

Cash Flow Statement

Trends Matrix
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditure(7.6 M)(6.4 M)(3.4 M)
Decreasing
Slightly volatile
Net Cash Flow Investment Acquisitions and Disposals(37 M)(31.5 M)(6.4 M)
Decreasing
Stable
Net Cash Flow from Financing2.7 M2.3 M33.1 M
Decreasing
Very volatile
Issuance Repayment of Debt Securities (277.6 K)(236 K)8.1 M
Decreasing
Stable
Issuance Purchase of Equity Shares3.3 M2.8 M29.3 M
Decreasing
Very volatile
Net Cash Flow from Investing(44.6 M)(37.9 M)(9.9 M)
Decreasing
Stable
Net Cash Flow from Operations(28.8 M)(83.7 M)(35.3 M)
Decreasing
Stable
Effect of Exchange Rate Changes on Cash 166.3 K141.3 K143.4 K
Increasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents(140.3 M)(119.2 M)(17.9 M)
Decreasing
Slightly volatile
Share Based Compensation17.3 M14.7 M10.1 M
Increasing
Slightly volatile

Fundamental Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share(3.0824)(2.62)(1.5719)
Decreasing
Slightly volatile
Earnings per Diluted Share(0.8)(2.62)(1.3842)
Decreasing
Slightly volatile
Earnings per Basic Share USD(3.0824)(2.62)(1.5719)
Decreasing
Slightly volatile
Return on Average Equity(0.6847)(1.166)(0.5852)
Decreasing
Slightly volatile
Return on Average Assets(0.2888)(0.454)(0.2621)
Decreasing
Slightly volatile
Return on Invested Capital(2.3459)(1.994)(0.8813)
Decreasing
Slightly volatile
Gross Margin1.17651.00.9638
Increasing
Slightly volatile
Profit Margin(1.3847)(1.177)(0.6416)
Decreasing
Slightly volatile
EBITDA Margin(1.3412)(1.14)(0.5871)
Decreasing
Slightly volatile
Return on Sales(1.3659)(1.161)(0.618)
Decreasing
Slightly volatile
Asset Turnover0.45410.3860.4826
Decreasing
Stable
Enterprise Value over EBITDA(2.5306)(2.151)(9.098)
Decreasing
Stable
Enterprise Value over EBIT(2.3529)(2.0)2.1373
Decreasing
Slightly volatile
Price to Earnings Ratio(1.63)(2.996)5.2447
Decreasing
Slightly volatile
Sales per Share2.61412.2223.105
Decreasing
Slightly volatile
Price to Sales Ratio18.323.5336.2973
Increasing
Stable
Price to Book Value2.323.9214.0903
Increasing
Very volatile
Debt to Equity Ratio12.51.932.4395
Increasing
Slightly volatile
Current Ratio10.83.6367.4345
Decreasing
Stable
Free Cash Flow per Share0.85(1.835)(0.7948)
Decreasing
Stable
Book Value per Share2.35762.0044.4463
Decreasing
Slightly volatile
Tangible Assets Book Value per Share6.90945.8737.3074
Decreasing
Slightly volatile
Total Assets Per Share6.89165.85786.0396
Increasing
Very volatile
Cash Flow Per Share(1.996)(1.6966)(0.9141)
Decreasing
Slightly volatile
Return on Investment(91.1722)(77.4964)(48.6942)
Decreasing
Slightly volatile
Operating Margin(591)(4.802)(74.9041)
Decreasing
Slightly volatile
Receivables Turnover1 K850653
Increasing
Slightly volatile
PPandE Turnover5.43584.62059.8942
Decreasing
Slightly volatile
Cash and Equivalents Turnover0.51780.44021.6516
Decreasing
Slightly volatile
Accounts Payable Turnover16.476814.005321.2379
Decreasing
Slightly volatile
Accrued Expenses Turnover6.05655.1486.2478
Increasing
Stable
Long Term Debt to Equity0.23390.19880.5245
Decreasing
Stable
Quick Ratio4.13813.51746.4807
Decreasing
Stable
Net Current Assets as percentage of Total Assets75.210863.929273.7197
Decreasing
Stable
Revenue to Assets0.44430.37760.4127
Increasing
Very volatile

Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax(150.6 M)(128 M)(69.1 M)
Decreasing
Slightly volatile
Market Capitalization109.9 M386.5 M416.9 M
Increasing
Stable
Enterprise Value63.8 M267.6 M338.8 M
Increasing
Very volatile
Invested Capital46.4 M39.3 M82.7 M
Decreasing
Slightly volatile
Average Equity129.6 M110.1 M115.8 M
Increasing
Slightly volatile
Average Assets332.5 M282.6 M214.7 M
Increasing
Slightly volatile
Invested Capital Average74.7 M63.5 M90.1 M
Decreasing
Stable
Tangible Asset Value339.8 M288.8 M234.6 M
Increasing
Slightly volatile
Free Cash Flow(106 M)(90.1 M)(44.4 M)
Decreasing
Slightly volatile
Working Capital184.6 M184.6 M168.7 M
Increasing
Slightly volatile
Revenue Per Employee578 K491.3 K496 K
Increasing
Slightly volatile
Net Income Per Employee(680.3 K)(578.3 K)(352.6 K)
Decreasing
Slightly volatile

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Infinity Pharmaceuticals Upcoming Company Events

Upcoming Quarterly ReportFebruary 28, 2017
Next Earnings ReportMay 3, 2017
Please also check analysis of Infinity Pharmaceuticals Correlation with competitors. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">